The Ginsenoside Rg1 Rescues Mitochondrial Disorders in Aristolochic Acid-Induced Nephropathic Mice

Chronic exposure to aristolochic acid (AA) leads to renal interstitial fibrosis and nephropathy. In this study, we aimed to investigate the renoprotective effects of Panax ginseng extract (GE) and ginsenoside saponin (GS) on AA-induced nephropathy (AAN) in mice. Eighty female C3H/He mice were randomly divided into eight groups, including normal; AA (3 mu g/mL for 56 days); AA with GE (125, 250, or 500 mg/kg/d for 14 days); and AA with important GE ingredients, Rg(1), Rb-1, or Rd (5 mg/kg/d for 14 days). Compared with the AA group, renal injuries were significantly decreased in the GE (250 mg/kg/d), Rb-1, and Rg(1) treatment groups. Rg(1) exhibited the best renoprotection among all GS-treated groups. There were 24 peaks significantly altered among normal, AA, and AA + Rg(1) groups, and four mitochondrial proteins were identified, including acyl-CoA synthetase medium-chain family member 2, upregulated during skeletal muscle growth 5 (Usmg5), mitochondrial aconitase 2 (ACO2), and cytochrome c oxidase subunit Va preprotein (COX5a). We demonstrated for the first time that the AAN mechanism and renoprotective effects of Rg(1) are associated with expression of mitochondrial proteins, especially ACO2, Usmg5, and COX5a.

Automated summary

This study revealed that Panax ginseng extract and ginsenoside saponin can significantly reduce renal injuries induced by aristolochic acid, with Rg(1) showing the best renoprotective effect among all GS-treated groups. The mechanism and renoprotective effects of Rg(1) were found to be associated with the expression of mitochondrial proteins, particularly ACO2, Usmg5, and COX5a.